ABOVE: Ò THE USE OF A SYSTEM SUCH AS THIS LEADS TO A GREATER UNDERSTANDING AND THE ABILITY TO DESIGN PHARMACOTHERAPIES FOR THESE DISEASESÓ

Jargon Buster

DNA The acronym for deoxyribonucleic acid

Therapeutics Treatment and care to combat disease and alleviate pain

Neurodegenerative The term for the progressive loss of structure or function of neurons

Ischemic stroke A stroke caused by a blood clot in an artery serving the brain

Chromosome An organised structure of DNA and protein found inside cells

Atherosclerosis The thickening of artery walls due to the build up of fatty materials such as cholesterol.

suffering caused by this range of degenerative diseases is enormous; there have not been any effective ways to combat the cause and prevent their progressions. They involve a huge cost to the healthcare industry of around $46 billion which includes the expanding pharmaceutical market.

The existing companies created to develop drugs specifically to combat neurodegenerative diseases have spent roughly $2 billion and have come up short; most have merged or disappeared completely. The remaining companies have made no advances in the past five to seven years. Verne Mendel Medical are looking for $3 million worth of investment to further their venture.

For more information on Verne Mendel Medical visit online vernemendel.com

THE -ELEVATOR.COM THE -ELEVATOR.COM

PAGE 45 Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100